Showing results (71-80 of 799) with videos related to
Sort By:
Pageof 80
JHEP Reports : Innovation in Hepatology|April 11, 2025
Pravastatin reduces all-cause mortality in elderly individuals at risk of liver fibrosis: Post hoc analysis of the PROSPER trialVivian de Jong, Willy Theel, Manuel Castro Cabezas, et al.Journal of Clinical Epidemiology|July 23, 2003
Diagnostic research on routine care data: prospects and problemsRianne Oostenbrink, Karel G M Moons, Sacha E Bleeker, et al.Heart Asia|April 30, 2019
Determinants of coronary artery disease risk factor management across three world regionsMin Zhao, Ian Graham, Marie Therese Cooney, et al.International Journal of Cardiology|August 9, 2008
Long-term prognosis of congenital heart defects: a systematic reviewCarianne L Verheugt, Cuno S P M Uiterwaal, Diederick E Grobbee, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 17, 2005
The 1944-1945 Dutch famine and subsequent overall cancer incidenceSjoerd G Elias, Petra H M Peeters, Diederick E Grobbee, et al.Trials|March 12, 2026
Participant satisfaction across three trial arms with varying degrees of decentralisation in the RADIAL proof-of-concept trialJulia Kopanz, Mira G P Zuidgeest, Linda Rutgrink, et al.Journal of Cardiac Failure|August 30, 2011
Clinical utility of three B-type natriuretic peptide assays for the initial diagnostic assessment of new slow-onset heart failureJohannes C Kelder, Maarten J Cramer, Wim M Verweij, et al.Global Health Action|September 30, 2022
Tuberculosis treatment and resulting abnormal blood glucose: a scoping review of studies from 1981 - 2021Victor Williams, Chukwuemeka Onwuchekwa, Alinda G Vos, et al.Plos One|January 26, 2016
Pro-Inflammatory Markers in Relation to Cardiovascular Disease in HIV Infection. A Systematic ReviewAlinda G Vos, Nikmah S Idris, Roos E Barth, et al.British Journal of Clinical Pharmacology|July 30, 2008
Does the European clinical trials directive really improve clinical trial approval time?Hiddo J Lambers Heerspink, Daniela Dobre, Hans L Hillege, et al.Pageof 80